Beta-D-Glucan in Patients with Haematological Malignancies
(1-3)-beta-D-glucan (BDG) is an almost panfungal marker (absent in zygomycetes and most cryptococci), which can be successfully used in screening and diagnostic testing in patients with haematological malignancies if its advantages and limitations are known. The aim of this review is to report the d...
Autori principali: | Malgorzata Mikulska, Elisa Balletto, Elio Castagnola, Alessandra Mularoni |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
MDPI AG
2021-12-01
|
Serie: | Journal of Fungi |
Soggetti: | |
Accesso online: | https://www.mdpi.com/2309-608X/7/12/1046 |
Documenti analoghi
Documenti analoghi
-
Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis
di: Siobhan O’Regan, et al.
Pubblicazione: (2022-05-01) -
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves
di: Letizia Cattaneo, et al.
Pubblicazione: (2023-01-01) -
Invasive Fungal Infections in Persons Living with HIV in an Amazonian Context: French Guiana, 2009–2019
di: Laurène Cachera, et al.
Pubblicazione: (2021-05-01) -
Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Neonates, Children and Adolescents: A Critical Analysis of Current Data
di: Laura Ferreras-Antolin, et al.
Pubblicazione: (2022-11-01) -
Epidemiology of Systemic Mycoses in the COVID-19 Pandemic
di: María Guadalupe Frías-De-León, et al.
Pubblicazione: (2021-07-01)